Sickle cell disease (SCD) is a complex, inherited blood disorder that affects millions of people worldwide, with a particularly high prevalence among individuals of African, Middle Eastern, Mediterranean, and South Asian descent. Despite its global impact, sickle cell disease often remains misunderstood and under-recognized, leading to gaps in care, research, and advocacy. At AWKO, we are committed to raising awareness, supporting those affected, and fighting for the rights of sickle cell patients, including securing compensation for SCD Warriors who suffered vasoocclusive crisis, acute chest syndrome and related injuries while taking the recalled drug Oxbryta.
What Is Sickle Cell Disease?
Sickle cell disease refers to a group of inherited red blood cell disorders caused by a mutation in the gene that tells the body how to make hemoglobin—the protein in red blood cells that carries oxygen. The most common and severe form is sickle cell anemia (HbSS), but several related conditions exist, including hemoglobin SC disease (HbSC) and sickle beta-thalassemia.
The Genetics Behind Sickle Cell Disease
SCD is inherited in an autosomal recessive pattern. This means a child must receive two sickle cell genes (one from each parent) to develop the disease. If a person inherits only one sickle cell gene, they are considered a carrier (sickle cell trait) and usually do not experience symptoms, but they can pass the gene to their children.
How Sickle Cell Disease Affects the Body
In SCD, the abnormal hemoglobin (hemoglobin S) causes red blood cells to become rigid, sticky, and shaped like crescent moons or sickles. These misshapen cells:
- Clump together and block blood flow in small blood vessels, causing pain and potential organ damage.
- Break down prematurely (hemolysis), leading to chronic anemia and fatigue.
- Have a much shorter lifespan (10-20 days vs. 120 days for normal red blood cells), resulting in a constant shortage of healthy red blood cells.
Signs and Symptoms of Sickle Cell Disease
Sickle cell disease symptoms usually begin in early childhood, often around five to six months of age. However, the severity and frequency of symptoms can vary widely.
Common Signs and Symptoms
- Anemia: Chronic shortage of healthy red blood cells causes persistent fatigue, weakness, shortness of breath, and pale or yellowish skin (jaundice).
- Pain Crises (Vaso-Occlusive Crises): Sudden, severe pain episodes are the hallmark of SCD. These crises occur when sickled cells block blood flow, most commonly affecting the bones, chest, abdomen, and joints. Pain can last from hours to weeks and may require hospitalization.
- Swelling of Hands and Feet: Known as dactylitis, this is often the first sign in infants and young children.
- Frequent Infections: The spleen, which helps fight infection, is often damaged early in life, making patients more vulnerable to bacterial and viral infections.
- Delayed Growth and Puberty: Chronic anemia and nutrient deficiencies can slow growth and delay puberty in children and teens.
- Vision Problems: Blocked blood vessels in the eyes can damage the retina, leading to vision loss.
- Jaundice: The rapid breakdown of red blood cells releases bilirubin, causing yellowing of the skin and eyes.
Serious Complications
- Acute Chest Syndrome: A life-threatening condition similar to pneumonia, marked by chest pain, fever, cough, and difficulty breathing. It is a leading cause of hospitalization and death in SCD patients.
- Stroke: Blocked blood flow to the brain can cause strokes, even in very young children.
- Organ Damage: Repeated blockages and chronic anemia can damage organs such as the liver, kidneys, lungs, and heart.
- Leg Ulcers: Chronic poor blood flow can cause painful, slow-healing sores on the legs.
- Priapism: Painful, prolonged erections in males that can cause permanent damage if not treated.
Diagnosis of Sickle Cell Disease
Early diagnosis is crucial for managing sickle cell disease and preventing complications. In the United States and many other countries, newborn screening for SCD is standard. Diagnosis involves:
- Hemoglobin Electrophoresis: A blood test that identifies abnormal types of hemoglobin.
- Genetic Testing: Confirms the presence of sickle cell genes.
- Prenatal Testing: Can detect SCD in unborn babies if both parents are carriers.
Treatment and Management of Sickle Cell Disease
While there is currently no universal cure for sickle cell disease, advances in treatment have improved life expectancy and quality of life for many patients.
Medications
- Hydroxyurea: Increases fetal hemoglobin, reducing the frequency of pain crises and acute chest syndrome.
- L-glutamine (Endari): Helps reduce the frequency of pain crises.
- Voxelotor (Oxbryta): Improves anemia by increasing hemoglobin levels and reducing hemolysis.
- Crizanlizumab (Adakveo): Reduces the frequency of pain crises by preventing blood cells from sticking together.
Blood Transfusions
Regular blood transfusions can help treat severe anemia and prevent complications like stroke, especially in children at high risk.
Stem Cell Transplantation
A bone marrow or stem cell transplant is currently the only potential cure for SCD. It is most successful in children with a matched sibling donor, but it carries significant risks and is not suitable for everyone.
Gene Therapy
Emerging gene-editing technologies offer hope for a future cure. Clinical trials are ongoing, and some patients have achieved remission, but these treatments are not yet widely available.
Supportive Care
- Pain Management: Both at home and in the hospital, using medications and alternative therapies.
- Preventive Care: Vaccinations, antibiotics, and regular checkups to prevent infections and monitor for complications.
- Healthy Lifestyle: Staying hydrated, eating a balanced diet, and avoiding extreme temperatures and high altitudes.
Living with Sickle Cell Disease
SCD is a lifelong condition that affects not just physical health, but emotional and social well-being. Patients may face:
- Frequent hospitalizations and missed school or work.
- Emotional challenges such as depression, anxiety, and social isolation.
- Financial burdens from medical bills and lost income.
Support from family, friends, healthcare providers, and advocacy organizations is vital. Patient education, mental health services, and community resources can make a significant difference in quality of life.
Sickle Cell Awareness Day: June 19
World Sickle Cell Awareness Day is observed every year on June 19. Established by the United Nations in 2008, this day is dedicated to increasing public knowledge and understanding of sickle cell disease, promoting early diagnosis and treatment, and supporting research for better therapies and a cure.
Why Sickle Cell Awareness Matters
- Dispelling Myths: Many people still misunderstand SCD, confusing it with other blood disorders or believing it only affects certain populations.
- Reducing Stigma: Raising awareness helps reduce discrimination and isolation experienced by patients.
- Encouraging Early Testing: Early diagnosis can prevent life-threatening complications.
- Driving Research Funding: Awareness campaigns help secure funding for new treatments and support services.
How to Get Involved
- Wear Red: Show your support on June 19 by wearing red and sharing information on social media.
- Participate in Events: Join local walks, educational seminars, or virtual events.
- Advocate for Change: Support policies that improve access to care, research funding, and patient rights.
AWKO: Advocates for the Sickle Cell Community
At AWKO, we stand with individuals and families affected by sickle cell disease. We understand the unique challenges you face and are committed to fighting for your rights, safety, and well-being.
Our Commitment
- Patient Advocacy: We support efforts to improve access to quality care, innovative treatments, and patient education for the sickle cell community.
- Legal Action: AWKO is currently representing clients in a lawsuit involving the medication Oxbryta (voxelotor), a drug marketed for the treatment of sickle cell disease. The lawsuit alleges that Oxbryta, developed by Global Blood Therapeutics (now a subsidiary of Pfizer), caused serious injuries and increased health risks for patients, including severe pain crises and even stroke. The case claims the manufacturer failed to adequately warn patients and doctors about these risks, resulting in harm to individuals who trusted the medication to help manage their disease.
- AWKO is proud to represent more clients in this Oxbryta lawsuit than any other law firm, making us the leading advocate for those seeking justice and accountability in this case.
- Raising Awareness: We actively participate in awareness campaigns and support research initiatives to find better treatments and ultimately a cure for sickle cell disease.
“Our firm is committed to ensuring that our Sickle Cell Disease (SCD) community is provided with adequate, safe, and effective pharmaceutical drug therapies,” said AWKO founding partner Bryan Aylstock. “We are proud of all of the SCD patients who have stepped forward to bring more awareness to this situation and will fight to ensure they receive the attention and justice they deserve.”
How AWKO Can Help
If you or a loved one has sickle cell disease and has experienced complications after taking Oxbryta or another medication, you are not alone. AWKO is here to support you. We are dedicated to fighting for the rights of sickle cell patients and ensuring that pharmaceutical companies are held accountable for unsafe products.
Contact AWKO today for a free consultation and let us help you seek justice and support.
Phone: (844) 794-7402
Email Us
Together, we can raise awareness, improve lives, and ensure that everyone living with sickle cell disease receives the care, respect, and justice they deserve.